EQS-News: Change in the Supervisory Board of Eckert & Ziegler AG
|
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG
/ Key word(s): Personnel
Berlin, 20.12.2022. Eckert Wagniskapital und Frühphasenfinanzierung GmbH has appointed radiation physicist Paola Eckert-Palvarini as its new representative on the Supervisory Board of Eckert & Ziegler AG (ISIN DE0005659700, SDAX). She replaces sinologist Jutta Ludwig, who will move to the Executive Board of Eckert & Ziegler AG as Asia Representative as of January 01, 2023. Ms. Eckert-Palvarini studied physics in Milan and in the past was, among others, member of the board at Eckert & Ziegler BEBIG SA, which was listed on the Brussels EURONEXT. The native Italian owns shares in Eckert & Ziegler AG's major shareholder Eckert Wagniskapital und Frühphasenfinanzierung GmbH and has been familiar with the group of companies for a long time. For enquiries please contact:
20.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Eckert & Ziegler Strahlen- und Medizintechnik AG |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | +49 30 941084-138 |
| Fax: | +49 30 941084-112 |
| E-mail: | [email protected] |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1518225 |
| End of News | EQS News Service |
|
|
1518225 20.12.2022 CET/CEST
Eckert & Ziegler Strahlen- und Medizintechnik AG Aktie
Eine klare Neigung zu Buy-Einschätzungen bei Eckert & Ziegler Strahlen- und Medizintechnik AG, ohne Sell-Einschätzungen.
Das Kursziel von 95 € für Eckert & Ziegler Strahlen- und Medizintechnik AG bedeutet eine deutliche Steigerung von über 50% gegenüber dem aktuellen Kurs von 48.02 €.
